July 26, 2018
Article
An Extraordinary Healer essay honoring MARY McMAHON, RN, OCN [THE CANCER INSTITUTE AT ST. FRANCIS HOSPITAL, EAST HILLS, NEW YORK]
FDA Approves Inlexzo for Some With Non–Muscle Invasive Bladder Cancer
Lunsumio plus Polivy Associated With Responses in MCL
Standing Up to Cancer with Lynch Syndrome
Zidesamtinib Elicits Responses in ROS1-Positive NSCLC